tetano
Editor, Senior Moderator
Eur Rev Med Pharmacol Sci
. 2020 Nov;24(21):11421-11427.
doi: 10.26355/eurrev_202011_23635.
Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients?
W-W Xiao[SUP] 1 [/SUP], J Xu, L Shi, Y-D Wang, H-Y Yang
Affiliations
Abstract
Objective: This study aimed to investigate whether pre-existing chronic obstructive pulmonary disease (COPD) was an independent predictor for adverse outcomes in coronavirus disease 2019 (COVID-19) patients.
Materials and methods: We searched electronic databases, including PubMed, Web of Science, EMBASE, and Chinese National Knowledge Infrastructure (CNKI) to screen for eligible articles. A quantitative meta-analysis was performed on the basis of adjusted effect estimates.
Results: We observed that COPD was significantly associated with an increased risk of adverse outcomes in COVID-19 patients, which is based on 18 studies with 26,075 cases reporting adjusted effect estimates (pooled effect = 1.53, 95% confidence interval (CI): 1.29-1.8; I2 = 35.4%, random-effects model).
Conclusions: We found that pre-existing COPD was an independent risk factor for predicting the adverse outcomes in COVID-19 patients.
. 2020 Nov;24(21):11421-11427.
doi: 10.26355/eurrev_202011_23635.
Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients?
W-W Xiao[SUP] 1 [/SUP], J Xu, L Shi, Y-D Wang, H-Y Yang
Affiliations
- PMID: 33215464
- DOI: 10.26355/eurrev_202011_23635
Abstract
Objective: This study aimed to investigate whether pre-existing chronic obstructive pulmonary disease (COPD) was an independent predictor for adverse outcomes in coronavirus disease 2019 (COVID-19) patients.
Materials and methods: We searched electronic databases, including PubMed, Web of Science, EMBASE, and Chinese National Knowledge Infrastructure (CNKI) to screen for eligible articles. A quantitative meta-analysis was performed on the basis of adjusted effect estimates.
Results: We observed that COPD was significantly associated with an increased risk of adverse outcomes in COVID-19 patients, which is based on 18 studies with 26,075 cases reporting adjusted effect estimates (pooled effect = 1.53, 95% confidence interval (CI): 1.29-1.8; I2 = 35.4%, random-effects model).
Conclusions: We found that pre-existing COPD was an independent risk factor for predicting the adverse outcomes in COVID-19 patients.